You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)
|
|---|---|
| Published in |
Annals of the Rheumatic Diseases, May 2012
|
| DOI | 10.1136/annrheumdis-2011-201282 |
| Pubmed ID | |
| Authors |
Maxime Dougados, Karsten Kissel, Tom Sheeran, Paul P Tak, Philip G Conaghan, Emilio Martín Mola, Georg Schett, Howard Amital, Federico Navarro-Sarabia, Antony Hou, Corrado Bernasconi, TWJ Huizinga |
| Abstract |
In patients with active rheumatoid arthritis (RA) despite methotrexate, to compare the efficacy of adding tocilizumab to that of switching to tocilizumab monotherapy. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 20% |
| Ecuador | 2 | 20% |
| United States | 1 | 10% |
| Australia | 1 | 10% |
| Unknown | 4 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 50% |
| Scientists | 2 | 20% |
| Practitioners (doctors, other healthcare professionals) | 1 | 10% |
| Science communicators (journalists, bloggers, editors) | 1 | 10% |
| Unknown | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 172 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 1% |
| Ecuador | 1 | <1% |
| Canada | 1 | <1% |
| Singapore | 1 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| Unknown | 165 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 29 | 17% |
| Student > Ph. D. Student | 24 | 14% |
| Student > Master | 19 | 11% |
| Other | 18 | 10% |
| Student > Postgraduate | 15 | 9% |
| Other | 40 | 23% |
| Unknown | 27 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 90 | 52% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 7% |
| Agricultural and Biological Sciences | 11 | 6% |
| Biochemistry, Genetics and Molecular Biology | 4 | 2% |
| Immunology and Microbiology | 3 | 2% |
| Other | 11 | 6% |
| Unknown | 41 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2023.
All research outputs
#1,451,561
of 25,837,817 outputs
Outputs from Annals of the Rheumatic Diseases
#833
of 7,833 outputs
Outputs of similar age
#7,876
of 179,323 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#3
of 115 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,833 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,323 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 115 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.